PACB Pacific Biosciences Calif Inc.
Industrials, filed as PACIFIC BIOSCIENCES CALIF IN (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
In 2026 Q3 Murray Stahl sold out of Pacific Biosciences Calif.
Who owns this now
Largest portfolio weights among holders, up to 0.4% (Cathie Wood, ARK Investment Management). Not free-float ownership.
Who owns PACB
Sorted by value, long equity only, as of 2026 Q3. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| Cathie Wood, ARK Investment Management | Small trim −0.1% | 29,749,893 | $71M | History | |
| Farallon Capital Management | Hold | 14,200 | $34K | History | |
| Murray Stahl, Horizon Kinetics Asset Management exited 2026 Q3 Last 2026 Q2 | Exit 0.00% | 10,068 | $17K | History |
Insider trades
Open-market buys and sales by PACB's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $33K sold by 1 insider outside a trading plan
- $2.1M sold by 1 insider under 10b5-1 plans
-
Kathy Ordonez DirectorSale$33K 18,595 shares at $1.78 4.6% of stakeTraded Nov 17 Filed Nov 19
-
James R. Gibson II See RemarksPlanned sale$2.1M 661,815 shares at $3.11 38% of stakeTraded Oct 6 Filed Oct 8
Also filed in the last 12 months, not counted as buying or selling: 11 sales to cover taxes, 8 stock grants, and 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 19 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 424B5 | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,5.02,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,2.05,5.02,7.01,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,7.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $742.05M | $495.68M | $375.05M |
| Total non-current assets * | $1B | $0.765B | $0.409B |
| Total assets | $1.75B | $1.26B | $0.784B |
| Total current liabilities | $95.03M | $66.3M | $72.83M |
| Total non-current liabilities * | $949.68M | $687.55M | $705.9M |
| Total equity | $701.3M | $506.59M | $5.35M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon